Barclays’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Buy |
387,908
+235,045
| +154% | +$799K | ﹤0.01% | 2484 |
|
|
2025
Q1 | $613K | Sell |
152,863
-62,561
| -29% | -$251K | ﹤0.01% | 2718 |
|
|
2024
Q4 | $1.4M | Buy |
215,424
+14,065
| +7% | +$91.2K | ﹤0.01% | 2432 |
|
|
2024
Q3 | $1.12M | Buy |
201,359
+154,915
| +334% | +$859K | ﹤0.01% | 2560 |
|
|
2024
Q2 | $259K | Sell |
46,444
-60,174
| -56% | -$336K | ﹤0.01% | 2907 |
|
|
2024
Q1 | $715K | Sell |
106,618
-82,725
| -44% | -$555K | ﹤0.01% | 2620 |
|
|
2023
Q4 | $1.73M | Buy |
189,343
+140,164
| +285% | +$1.28M | ﹤0.01% | 2251 |
|
|
2023
Q3 | $271K | Buy |
49,179
+411
| +0.8% | +$2.27K | ﹤0.01% | 2873 |
|
|
2023
Q2 | $416K | Sell |
48,768
-9,021
| -16% | -$77K | ﹤0.01% | 2713 |
|
|
2023
Q1 | $531K | Buy |
57,789
+27,130
| +88% | +$249K | ﹤0.01% | 2603 |
|
|
2022
Q4 | $313K | Buy |
30,659
+25,818
| +533% | +$264K | ﹤0.01% | 2863 |
|
|
2022
Q3 | $71K | Sell |
4,841
-12,810
| -73% | -$188K | ﹤0.01% | 3543 |
|
|
2022
Q2 | $189K | Sell |
17,651
-15,005
| -46% | -$161K | ﹤0.01% | 3160 |
|
|
2022
Q1 | $351K | Buy |
+32,656
| New | +$351K | ﹤0.01% | 3008 |
|